SBIR Phase II: Tissue Engineered Cartilage for Drug Discovery

Award Information
Agency:
National Science Foundation
Amount:
$499,914.00
Program:
SBIR
Contract:
0422194
Solitcitation Year:
N/A
Solicitation Number:
N/A
Branch:
N/A
Award Year:
2004
Phase:
Phase II
Agency Tracking Number:
0320087
Solicitation Topic Code:
N/A
Small Business Information
Articular Engineering, LLC
1818 Skokie Blvd. Suite 158, Northbrook, IL, 60062
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 Brian Pfister
 PI
 (847) 498-9634
 kmasuda@articular.com
Business Contact
 Brian Pfister
Phone: (847) 498-9634
Email: bpfister@articular.com
Research Institution
N/A
Abstract
This Small Business Innovation Research Phase II project is to develop scale-up production technology to produce engineered cartilage for drug discovery using a proprietary Alginate Recovered Chondrocyte (ARC) method. This method stimulates adult human cartilage cells to form a cartilaginous tissue with proper compositional and functional properties. ARC cartilage tissue is expected to offer a cost-effective alternative to current culture systems and expensive animal studies while utilizing human tissue. The commercial application of this project will be in the area of drug discovery for cartilage-related problems such as rheumatoid arthritis.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government